[Catheter ablation in patients with atrial fibrillation: what will change in daily practice?]

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Paroxysmal atrial fibrillation (AF) management often involves antiarrhythmic drugs or catheter ablation.
• Objective measurement of AF burden is crucial for treatment efficacy assessment.

Purpose of the Study:

• To compare the efficacy of initial catheter ablation versus antiarrhythmic drugs in managing paroxysmal AF.
• To evaluate the cumulative AF burden over a two-year period using objective ECG monitoring.

Main Methods:

• A study compared catheter ablation with antiarrhythmic drugs for initial paroxysmal AF therapy.
• AF burden was objectively measured using serial 7-day continuous ECG recordings.
• Limitations included an outdated ablation endpoint and variable center volumes.

Main Results:

• No significant difference was observed in the primary endpoint of cumulative AF burden between the two groups.
• Secondary outcome measures showed a trend favoring catheter ablation.
• Both treatment strategies resulted in relatively good patient outcomes.

Conclusions:

• The study did not demonstrate a significant difference in AF burden between initial catheter ablation and antiarrhythmic drugs.
• Despite limitations, secondary outcomes suggest potential benefits of ablation.
• Current practice for most paroxysmal AF patients is unlikely to change, but ablation remains a viable initial therapy option.